| Product Code: ETC9561229 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Opioid Receptor Agonist Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Opioid Receptor Agonist Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Opioid Receptor Agonist Market - Industry Life Cycle |
3.4 Sweden Opioid Receptor Agonist Market - Porter's Five Forces |
3.5 Sweden Opioid Receptor Agonist Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 Sweden Opioid Receptor Agonist Market Revenues & Volume Share, By Receptor Binding, 2021 & 2031F |
3.7 Sweden Opioid Receptor Agonist Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Sweden Opioid Receptor Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Sweden Opioid Receptor Agonist Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Sweden Opioid Receptor Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sweden Opioid Receptor Agonist Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in Sweden |
4.2.2 Growing awareness and acceptance of opioid therapies for pain management |
4.2.3 Technological advancements leading to the development of new and more effective opioid receptor agonists |
4.3 Market Restraints |
4.3.1 Stringent regulatory policies and guidelines surrounding the use of opioid medications |
4.3.2 Rising concerns about opioid misuse, addiction, and overdose |
4.3.3 Competition from alternative non-opioid pain management therapies |
5 Sweden Opioid Receptor Agonist Market Trends |
6 Sweden Opioid Receptor Agonist Market, By Types |
6.1 Sweden Opioid Receptor Agonist Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Fentanyl, 2021- 2031F |
6.1.4 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Codeine, 2021- 2031F |
6.1.5 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Morphine, 2021- 2031F |
6.1.6 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Buprenorphine, 2021- 2031F |
6.1.7 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Sweden Opioid Receptor Agonist Market, By Receptor Binding |
6.2.1 Overview and Analysis |
6.2.2 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Full Agonist, 2021- 2031F |
6.2.3 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Partial Agonist, 2021- 2031F |
6.3 Sweden Opioid Receptor Agonist Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Pain management, 2021- 2031F |
6.3.3 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Cough Suppression, 2021- 2031F |
6.3.4 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Diarrhoea suppression, 2021- 2031F |
6.3.5 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Sweden Opioid Receptor Agonist Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.4.3 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.4 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Sweden Opioid Receptor Agonist Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Sweden Opioid Receptor Agonist Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 Sweden Opioid Receptor Agonist Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Sweden Opioid Receptor Agonist Market Import-Export Trade Statistics |
7.1 Sweden Opioid Receptor Agonist Market Export to Major Countries |
7.2 Sweden Opioid Receptor Agonist Market Imports from Major Countries |
8 Sweden Opioid Receptor Agonist Market Key Performance Indicators |
8.1 Prescription rates of opioid receptor agonists by healthcare providers in Sweden |
8.2 Patient adherence and compliance rates to prescribed opioid therapies |
8.3 Number of clinical trials and research studies conducted on opioid receptor agonists in Sweden |
9 Sweden Opioid Receptor Agonist Market - Opportunity Assessment |
9.1 Sweden Opioid Receptor Agonist Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 Sweden Opioid Receptor Agonist Market Opportunity Assessment, By Receptor Binding, 2021 & 2031F |
9.3 Sweden Opioid Receptor Agonist Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Sweden Opioid Receptor Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Sweden Opioid Receptor Agonist Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Sweden Opioid Receptor Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sweden Opioid Receptor Agonist Market - Competitive Landscape |
10.1 Sweden Opioid Receptor Agonist Market Revenue Share, By Companies, 2024 |
10.2 Sweden Opioid Receptor Agonist Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here